Brief: Olema Oncology announces pricing of $190 million public offering of common stock
19/11/2025 12:21
Nov 19 (Reuters) - Olema Pharmaceuticals Inc OLMA.O: OLEMA ONCOLOGY ANNOUNCES PRICING OF $190.0 MILLION PUBLIC OFFERING OF COMMON STOCK OLEMA ONCOLOGY ANNOUNCES PRICING OF $190.0 MILLION PUBLIC OFFERING OF COMMON STOCK OLEMA PHARMACEUTICALS INC - PRICES PUBLIC OFFERING OF 10 MILLION SHARES AT $19.00 EACH Source text: nGNX1sLq65 Further company coverage: OLMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Olema Pharmaceuticals
See all newsOlema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Olema Pharmaceuticals Q2 net loss widens on higher clinical trial spending
Brief: Olema Pharmaceuticals Q2 Net Income USD -63.2 Million
Brief: Olema Oncology Announces Clinical Trial Collaboration And Supply Agreement With Bayer To Evaluate Op-3136 In Combination With Nubeqa® (Darolutamide) In Metastatic Castration-Resistant Prostate Cancer
Olema Pharmaceuticals Q1 net loss widens on higher R&D costs